79 related articles for article (PubMed ID: 7590419)
21. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
[TBL] [Abstract][Full Text] [Related]
22. Determinants of clinical remission in recent-onset IDDM.
Hramiak IM; Dupre J; Finegood DT
Diabetes Care; 1993 Jan; 16(1):125-32. PubMed ID: 8422766
[TBL] [Abstract][Full Text] [Related]
23. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA;
Diabet Med; 2011 Feb; 28(2):156-61. PubMed ID: 21219422
[TBL] [Abstract][Full Text] [Related]
24. Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
Schober E; Schernthaner G; Frisch H; Fink M
J Endocrinol Invest; 1984 Oct; 7(5):507-12. PubMed ID: 6392401
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
[TBL] [Abstract][Full Text] [Related]
27. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
[TBL] [Abstract][Full Text] [Related]
28. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
[TBL] [Abstract][Full Text] [Related]
29. Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.
Koivisto VA; Aro A; Cantell K; Haataja M; Huttunen J; Karonen SL; Mustajoki P; Pelkonen R; Seppälä P
Diabetologia; 1984 Aug; 27(2):193-7. PubMed ID: 6386581
[TBL] [Abstract][Full Text] [Related]
30. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin.
Christie MR; Mølvig J; Hawkes CJ; Carstensen B; Mandrup-Poulsen T;
Diabetes Care; 2002 Jul; 25(7):1192-7. PubMed ID: 12087018
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of early cyclosporin therapy in juvenile IDDM.
De Filippo G; Carel JC; Boitard C; Bougnères PF
Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.
Jenner M; Bradish G; Stiller C; Atkison P
Diabetologia; 1992 Sep; 35(9):884-8. PubMed ID: 1397785
[TBL] [Abstract][Full Text] [Related]
33. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
Ludvigsson J; Heding LG; Larsson Y; Leander E
Acta Paediatr Scand; 1977 Mar; 66(2):177-84. PubMed ID: 402787
[TBL] [Abstract][Full Text] [Related]
34. [Development of insulin reserves in the first 18 months in the insulin-dependent diabetic with or without remission of insulin-dependence].
Brucker F; Boda-Buccino M; Bellet C; Fredenrich A; Fenichel P; Claude MH; Hieronimus S; Harter M
Presse Med; 1988 Dec; 17(44):2340-3. PubMed ID: 2974970
[TBL] [Abstract][Full Text] [Related]
35. Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.
Fonolleda M; Murillo M; Vázquez F; Bel J; Vives-Pi M
Horm Res Paediatr; 2017; 88(5):307-315. PubMed ID: 28772271
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1.
Vondra K; Voborská M; Kvapil M; Weber P; Dvoráková H; Stanická S; Zamrazil V
Physiol Res; 2004; 53(1):115-7. PubMed ID: 14984323
[TBL] [Abstract][Full Text] [Related]
37. C-peptide response to arginine stimulation in diabetic children.
Menchini M; Meschi F; Lambiase R; Puzzovio M; Del Guercio MJ; Chiumello G
J Pediatr; 1980 Mar; 96(3 Pt 1):362-6. PubMed ID: 6987353
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
[TBL] [Abstract][Full Text] [Related]
39. [Remission induced at the early stage of insulin-dependent diabetes: do predictive factors exist?].
Sudre Y; Marechaud R; Rossi F; Abadie JC; Gouet D
Rev Med Interne; 1984 Sep; 5(3):206-11. PubMed ID: 6390593
[TBL] [Abstract][Full Text] [Related]
40. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.
Mirouze J; Selam JL; Pham TC; Mendoza E; Orsetti A
Diabetologia; 1978 Apr; 14(4):223-7. PubMed ID: 640299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
